Physician profile
Ted Bloch
NPI 1558412940
$1,537.01
in general payments reported to CMS, 2019-2025
11 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $373 · 2020: $152 · 2021: $278 · 2022: $234 · 2023: $357 · 2024: $43.33 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $269.54 | 2019-2022 | |
| Axsome Therapeutics, INC. | $231.73 | 2023 | Auvelity |
| Idorsia Pharmaceuticals US INC | $208.33 | 2022-2023 | Quviviq |
| Allergan, INC. | $182.45 | 2019-2020 | |
| Abbvie INC. | $134.55 | 2021 | |
| Corium, LLC | $124.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $105.91 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $93.33 | 2024-2025 | Rexulti |
| Ironshore Pharmaceuticals INC. | $82.64 | 2019 | |
| Neurocrine Biosciences, INC. | $53.54 | 2019 | |
| Eisai INC. | $50.00 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Bloch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.